Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1071-1080 of 10621

Edit search filters
  1. Management of Etonogestrel Subdermal Implant-related Bleeding

    Rochester, MN

  2. Endoscopic Full Thickness Biopsy, Gastric Wall.

    Rochester, MN

  3. Stem Cell Fistula Plug in Perianal Crohn's Disease

    Rochester, MN

  4. Continued Access to PREVAIL (CAP2)

    Rochester, MN

  5. Aspiration for Pain Relief Following Ankle Fracture

    Rochester, MN

  6. Serum Bovine Immunoglobulin Protein Isolate in Improving Quality of Life and Post-Operative Recovery in Patients With Gynecological Cancer After Undergoing Surgery

    Rochester, MN

  7. Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer

    Rochester, MN, Scottsdale/Phoenix, AZ

  8. Safety and Efficacy Study of PRI-724 in Subjects With Advanced Solid Tumors

    Scottsdale/Phoenix, AZ, Rochester, MN

  9. Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma

    Rochester, MN

  10. Safety Study of Mocetinostat in Combination With Azacitidine in Subjects With MDS

    Rochester, MN

.

Mayo Clinic Footer